Heart drug safety showdown: can older medication match standard care?
NCT ID NCT07405671
Summary
This study aims to determine if the heart rhythm medication flecainide is as safe as standard drugs (sotalol or amiodarone) for people who have both atrial fibrillation (an irregular heartbeat) and stable coronary artery disease (narrowed heart arteries). Researchers will randomly assign nearly 1,000 adult participants to receive either flecainide or one of the standard medications and follow them for at least one year. The main goal is to compare serious side effects, hospitalizations, and deaths between the two treatment groups.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.